Arthritis Res Ther February 2009 PMID 18667054

A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.

Krishanu Sengupta, Krishnaraju V Alluri, Andey Rama Satish, Simanchala Mishra, Trimurtulu Golakoti, Kadainti Vs Sarma, Dipak Dey, Siba P Raychaudhuri

Download social card

Mentions

27
Peak: 4 in Apr 2025
across 6 sources since Oct 2023

Extended reach

20,678
potential audience

Total likes

523

Video views

19,059

Mentions per month

Oct 2023 – May 2025

Where it's discussed

  • Facebook11 posts
  • News6 articles
  • YouTube4 videos
  • Blogs3 articles
  • Bluesky2 posts
  • X / Twitter1 posts

AI synopsis

What people are saying

Discussions express moderate support and curiosity about the research, with posts highlighting the promising results for pain relief and safety, such as mentions of improved joint function and reduced cartilage-degrading enzymes, while also raising questions about the broader clinical significance; the tone and word choice reflect cautious optimism and ongoing inquiry into the supplement's potential.

AgreementModerate agreement

Most discussions acknowledge the positive findings of the study, highlighting its evidence for pain reduction and safety of 5-Loxin, though some remain skeptical about its practical significance.

InterestModerate interest

Participants show moderate interest, with mentions of potential applications and questions about dosages, indicating some engagement but not intense curiosity.

EngagementModerate engagement

Comments include references to the study design and implications, suggesting a thoughtful level of participation, though many are brief or surface-level.

ImpactModerate impact

The discussions imply that the findings could influence supplement choices and future research directions, showing a modest but noteworthy perceived impact.

Abstract in brief

  • The study investigated the effectiveness and safety of 5Loxin, a Boswellia serrata extract, in treating knee osteoarthritis, finding that both 100 mg and 250 mg doses significantly improved pain and physical function over 90 days, with notable improvements as early as 7 days in the higher dose group.
  • The research involved 75 patients who were randomly assigned to receive either 5Loxin or a placebo, and assessments included pain scales, functional indices, and biochemical analysis of synovial fluid, serum, and urine, showing reduced levels of cartilage-degrading enzymes and no significant safety concerns.
  • Overall, 5Loxin demonstrated potential as a safe supplement that reduces pain and enhances joint function in osteoarthritis patients, with the higher dose offering quicker symptomatic relief.

Top posts

Most liked on X and Bluesky
Andrew Waye, PhD
@cannabis-scientist.bsky.social · Bluesky

A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality pubmed.ncbi.nlm.nih.gov/37796540/

Oct 19, 2023 · 2 likes · 2 shares View post →
Biogrow
@biogrow.bsky.social · Bluesky

Study of 100 participants / 26 weeks. Half received yeast beta-glucan and half received a placebo. Source: Graubaum et al., Food and Nutrition Sciences (2012) - A Double-Blind, Randomized, Placebo-Controlled Study on Beta-Glucan

May 13, 2025 · 2 likes View post →

All mentions

Biogrow
@biogrow.bsky.social · Bluesky

Study of 100 participants / 26 weeks. Half received yeast beta-glucan and half received a placebo. Source: Graubaum et al., Food and Nutrition Sciences (2012) - A Double-Blind, Randomized, Placebo-Controlled Study on Beta-Glucan

May 13, 2025 · 2 likes View post →
Mike Fave
@MikeFaveScience · X

Sources Cont: https://t.co/oYrxyqdmt6 https://t.co/qsVAPAaZWk https://t.co/grX1505Scd https://t.co/kVs1U4CpvJ https://t.co/g6sJBnsLP3 https://t.co/Ae1pxB5Tsb

Apr 4, 2025 · 1 like · 1,616 followers View post →
Andrew Waye, PhD
@cannabis-scientist.bsky.social · Bluesky

A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality pubmed.ncbi.nlm.nih.gov/37796540/

Oct 19, 2023 · 2 likes · 2 shares View post →